Data Supplement

• Supplemental Figures -

  Supplemental figure 1. Effect of IFNG, Dex or IL1B with each dual treatment on TLR2 expression in A549 cells.
  

  Supplemental figure 2. Effect of IL1B, IFNG and budesonide on TLR2 expression in air-liquid interface primary human bronchial epithelial cells.
  

  Supplemental figure 3. Effect of IL1B, IFNG and glucocorticoids on GAPDH mRNA.
  

  Supplemental figure 4. NF- κB inhibition by IKK inhibitors and effects of IL1B, IFNG and Dex on NF-κB, GRE and STAT1 reporter activity.
  

  Supplemental figure 5. Effect of Org 34517 on the enhancement of IL1B plus IFNG-induced TLR2 expression by dexamethasone.
  

  Supplemental figure 6. Effect of IL1B, glucocorticoid and IFNG on STAT1 phosphorylation.
  

  Supplemental figure 7. Effect of IL1B, IFNG, Dex and JAK inhibitors on total STAT1 expression.
  

  Supplemental figure 8. EC₅₀ values for the effect of JAK inhibitors on STAT1 phosphorylation at Y701 and S727.
  

  Supplemental figure 9. Effect of IFNG and JAK inhibitors on STAT1 reporter activity.
  

  Supplemental figure 10. Effect of STAT1 siRNAs on STAT1 expression.
  

  Supplemental figure 11. Effect of p65 siRNAs on p65 expression and NF-κB activity.